Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Handbook of Experimental Pharmacology
|
October 23, 2015
Predictive In Vivo Models for Oncology
Diana Behrens, Jana Rolff, Jens Hoffmann
Breast Cancer Research and Treatment
|
November 6, 2004
Liposomal 4-hydroxy-tamoxifen: effect on cellular uptake and resulting cytotoxicity in drug resistant breast cancer cells in vitro
Reinhard Zeisig, Anne-Dorthee Teppke, Diana Behrens, et al.
Biochimica Et Biophysica Acta
|
February 6, 2004
Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro
Reinhard Zeisig, Renate Stahn, Katrin Wenzel, et al.
Oncotarget
|
October 8, 2016
Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer
Giuseppina Sannino, Nicole Armbruster, Mona Bodenhöfer, et al.
Cancers
|
September 10, 2021
Effective Oncoleaking Treatment of Pancreatic Cancer by Claudin-Targeted Suicide Gene Therapy with <i>Clostridium perfringens</i> Enterotoxin (CPE)
Jessica Pahle, Dennis Kobelt, Jutta Aumann, et al.
International Journal of Oncology
|
January 5, 2006
Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo
Martin Michaelis, Iduna Fichtner, Diana Behrens, et al.
Molecular Oncology
|
February 8, 2014
Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector
Dennis Kobelt, Jutta Aumann, Manuel Schmidt, et al.
Plos One
|
May 7, 2014
The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells
Torben Redmer, Yvonne Welte, Diana Behrens, et al.
Oncotarget
|
October 15, 2017
The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators
Brajesh P Kaistha, Anja Krattenmacher, Johannes Fredebohm, et al.
Peptides
|
November 30, 2023
EPI-X4, a CXCR4 antagonist inhibits tumor growth in pancreatic cancer and lymphoma models
Micah N Sagini, Michael Zepp, Ergül Eyol, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Handbook of Experimental Pharmacology
|
October 23, 2015
Predictive In Vivo Models for Oncology
Diana Behrens, Jana Rolff, Jens Hoffmann
Breast Cancer Research and Treatment
|
November 6, 2004
Liposomal 4-hydroxy-tamoxifen: effect on cellular uptake and resulting cytotoxicity in drug resistant breast cancer cells in vitro
Reinhard Zeisig, Anne-Dorthee Teppke, Diana Behrens, et al.
Biochimica Et Biophysica Acta
|
February 6, 2004
Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro
Reinhard Zeisig, Renate Stahn, Katrin Wenzel, et al.
Oncotarget
|
October 8, 2016
Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer
Giuseppina Sannino, Nicole Armbruster, Mona Bodenhöfer, et al.
Cancers
|
September 10, 2021
Effective Oncoleaking Treatment of Pancreatic Cancer by Claudin-Targeted Suicide Gene Therapy with <i>Clostridium perfringens</i> Enterotoxin (CPE)
Jessica Pahle, Dennis Kobelt, Jutta Aumann, et al.
International Journal of Oncology
|
January 5, 2006
Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo
Martin Michaelis, Iduna Fichtner, Diana Behrens, et al.
Molecular Oncology
|
February 8, 2014
Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector
Dennis Kobelt, Jutta Aumann, Manuel Schmidt, et al.
Plos One
|
May 7, 2014
The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells
Torben Redmer, Yvonne Welte, Diana Behrens, et al.
Oncotarget
|
October 15, 2017
The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators
Brajesh P Kaistha, Anja Krattenmacher, Johannes Fredebohm, et al.
Peptides
|
November 30, 2023
EPI-X4, a CXCR4 antagonist inhibits tumor growth in pancreatic cancer and lymphoma models
Micah N Sagini, Michael Zepp, Ergül Eyol, et al.
Page
of 3